secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2026-06-15T23:44:44+00:00
Accession:  0001493152-26-028775
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos enters collaboration with Florida cardiology group to launch AIM Florida sleep apnea venture
--------------------------------------------------------------------------------

- Vivos expects to hold ≥80% membership interest in AIM Florida; SPCVA up to 20%, subject to definitive docs.
- SPCVA is a multi-location cardiology practice with ~30,000 patients; initial focus on Palm Beach County.
- One fully staffed team is planned to serve ~250 patients/month, projecting >$6M annual revenue and ~50% contribution margin.
- Model based on Vivos' successful Nevada sleep centers but requires no upfront capital outlay.
- Definitive operating agreement and ancillary contracts remain to be negotiated; no assurance of completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226028775/0001493152-26-028775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226028775/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer